almitrine has been researched along with Airflow Obstruction, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domingo, C; Marín, A; Morón, A; Rué, M; Saas-Torres, J; Sans-Torres, J | 1 |
| Didur, MD; Ignat'ev, VA; Kameneva, MIu; Sukhovskaia, OA; Titova, ON | 1 |
| Górecka, D; Pachocki, R; Palasiewicz, G; Sliwinski, P; Zielinski, J | 1 |
3 trial(s) available for almitrine and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
Topics: Aged; Almitrine; Analysis of Variance; Carbon Dioxide; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Hypoxia; Male; Oxygen; Partial Pressure; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory System Agents; Vital Capacity | 2003 |
[Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Almitrine; Bronchodilator Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exercise Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome | 2008 |
[Comparative changes in PaO2 in moderately hypoxemic COPD patients treated with almitrine versus placebo for one year].
Topics: Aged; Almitrine; Female; Humans; Hypoxia; Male; Middle Aged; Oxygen; Placebos; Pulmonary Disease, Chronic Obstructive; Respiratory System Agents; Treatment Outcome | 2001 |